|
2014 Featured Talks » Androgen Receptor Signaling Axis on CRPC – The A to Z in Drug Development
Part One
Part Two
Androgen Receptor Signaling Axis on CRPC – The A to Z in Drug Development
NamPhuong Tran, MD
Janssen R&D
NamPhuong Tran, MD
Director Clinical Research
Janssen R&D
Dr. Tran is a Director of Clinical Research at Janssen R&D. She joined Cougar Biotechnology in 2008 to work on the abiraterone acetate Clinical Development Program in the area of Prostate Cancer. After the acquisition of Cougar Biotechnology by Johnson & Johnson in 2009, Dr. Tran continued her work in Prostate cancer serving as clinical study leader for many of the Phase I and II abiraterone acetate clinical trials. Currently she is the clinical study leader for an active large Janssen global abiraterone acetate phase III study in the metastatic hormone-naïve prostate cancer.
Dr. Tran earned her MD degree from Stanford University School of Medicine. She completed her Internal Medicine Residency at Stanford and her Oncology fellowship at USCF.
|